Introduction: Since 1996, the preferred approach for positioning the active middle-ear implant Vibrant Soundbridge© is a mastoidectomy and a posterior tympanotomy. With this device, placement of the floating mass transducer (FMT) on the long incus process is the standard method for treatment of mild-to-severe sensorineural hearing loss in the case of normal middle-ear anatomy. The aim of this study was to determine the vibrational effectiveness of FMT placement at the short incus process. Materials and Methods: An extended antrotomy and a posterior tympanotomy were performed in 5 fresh human temporal bones. As a control for normal middle-ear function, the tympanic membrane was stimulated acoustically and the vibration of the stapes footplate and the round-window (RW) membrane were (sequentially) measured by laser Doppler vibrometry. Vibration responses for coupling of an FMT to the long incus process (standard coupling) were compared to those for coupling to the short incus process. Results: Apart from narrow frequency bands near 3 and 9 kHz for the stapes footplate and RW membrane, respectively, the velocity responses presented no significant differences between standard coupling of the FMT and coupling to the short incus process. Conclusion: Coupling the FMT to the short incus process may be a viable alternative in cases where the surgical approach is limited to an extended antrotomy. A reliable technique for attachment to the short incus process has yet to be developed.

1.
Baumgartner WD, Böheim K, Hagen R, Müller J, Lenarz T, Reiss S, Schlögel M, Mlynski R, Mojallal H, Colletti V, Opie J: The vibrant soundbridge for conductive and mixed hearing losses: European multicenter study results. Adv Otorhinolaryngol 2010;69:38-50.
2.
Beleites T, Neudert M, Beutner D, Hüttenbrink KB, Zahnert T: Experience with vibroplasty couplers at the stapes head and footplate. Otol Neurotol 2011;32:1468-1472.
3.
Böheim K, Mlynski R, Lenarz T, Schlögel M, Hagen R: Round window vibroplasty: long-term results. Acta Otolaryngol 2012;132:1042-1048.
4.
Brito R, Monteiro TA, Leal AF, Tsuji RK, Pinna MH, Bento RF: Surgical complications in 550 consecutive cochlear implantation. Braz J Otorhinolaryngol 2012;78:80-85.
5.
Bruschini L, Forli F, Giannarelli M, Bruschini P, Berrettini S: Exclusive transcanal surgical approach for Vibrant Soundbridge implantation: surgical and functional results. Otol Neurotol 2009;30:950-955.
6.
Cohen NL, Hoffman RA: Complications of cochlear implant surgery in adults and children. Ann Otol Rhinol Laryngol 1991;100:708-711.
7.
Colletti V, Soli SD, Carner M, Colletti L: Treatment of mixed hearing losses via implantation of a vibratory transducer on the round window. Int J Audiol 2006;45:600-608.
8.
Cremers CW, O'Connor AF, Helms J, Roberson J, Clarós P, Frenzel H, Profant M, Schmerber S, Streitberger C, Baumgartner WD, Orfila D, Pringle M, Cenjor C, Giarbini N, Jiang D, Snik AF: International consensus on Vibrant Soundbridge® implantation in children and adolescents. Int J Pediatr Otorhinolaryngol 2010;74:1267-1269.
9.
Decraemer WF, de La Rochefoucauld O, Dong W, Khanna SM, Dirckx JJ, Olson ES: Scala vestibuli pressure and three-dimensional stapes velocity measured in direct succession in gerbil. J Acoust Soc Am 2007;121:2774-2791.
10.
Fisch U, Cremers CW, Lenarz T, Weber B, Babighian G, Uziel AS, Proops DW, O'Connor AF, Charachon R, Helms J, Fraysse B: Clinical experience with the Vibrant Soundbridge implant device. Otol Neurotol 2001;22:962-972.
11.
Fredrickson JM, Coticchia JM, Khosla S: Ongoing investigations into an implantable electromagnetic hearing aid for moderate to severe sensorineural hearing loss. Otolaryngol Clin North Am 1995;28:107-120.
12.
Guinan JJ, Peake WT: Middle-ear characteristics of anesthetized cats. J Acoust Soc Am 1967;41:1237-1261.
13.
Huber AM, Mlynski R, Müller J, Dillier N, Holzmann D, Wolframm MD, Hagen R: A new vibroplasty coupling technique as a treatment for conductive and mixed hearing losses: a report of 4 cases. Otol Neurotol 2012;33:613-617.
14.
Jenkins HA, Niparko JK, Slattery WH, Neely JG, Fredrickson JM: Otologics Middle Ear Transducer Ossicular Stimulator: performance results with varying degrees of sensorineural hearing loss. Acta Otolaryngol 2004;124:391-394.
15.
Junker R, Gross M, Todt I, Ernst A: Functional gain of already implanted hearing devices in patients with sensorineural hearing loss of varied origin and extent: Berlin experience. Otol Neurotol 2002;23:452-456.
16.
Klein K, Nardelli A, Stafinski T: A systematic review of the safety and effectiveness of fully implantable middle ear hearing devices: the Carina and Esteem systems. Otol Neurotol 2012;33:916-921.
17.
Lenarz T, Weber BP, Issing PR, Gnadeberg D, Ambjørnsen K, Mack KF, Winter M: Vibrant Sound Bridge System. A new kind hearing prosthesis for patients with sensorineural hearing loss. 2. Audiological results. Laryngorhinootologie 2001;80:370-380.
18.
Maniglia AJ, Ko WH, Rosenbaum M, Zhu WL, Werning J, Belser R, Drago P, Falk T, Frenz W: A contactless electromagnetic implantable middle ear device for sensorineural hearing loss. Ear Nose Throat J 1994;73:78-90.
19.
Mlynski R, Müller J, Hagen R: Surgical approaches to position the Vibrant Soundbridge in conductive and mixed hearing loss. Operative Techniques in Otolaryngology 2010;21:272-277.
20.
Mosnier I, Sterkers O, Bouccara D, Labassi S, Bebear JP, Bordure P, Dubreuil C, Dumon T, Frachet B, Fraysse B, Lavieille JP, Magnan J, Martin C, Meyer B, Mondain M, Portmann D, Robier A, Schmerber S, Thomassin JM, Truy E, Uziel A, Vanecloo FM, Vincent C, Ferrary E: Benefit of the Vibrant Soundbridge device in patients implanted for 5 to 8 years. Ear Hear 2008;29:281-284.
21.
Needham AJ, Jiang D, Bibas A, Jeronimidis G, Fitzgerald O'Connor A: The effects of mass loading the ossicles with a floating mass transducer on middle ear transfer function. Otol Neurotol 2005;26:218-224.
22.
Park I-Y, Shimizu Y, O'Connor KN, Puria S, Cho J-H: Comparisons of electromagnetic and piezoelectric floating-mass transducers in human cadaveric temporal bones. Hear Res 2011;272:187-192.
23.
Rosowski JJ, Chien W, Ravicz ME, Merchant SN: Testing a method for quantifying the output of implantable middle ear hearing devices. Audiol Neurotol 2007;12:265-276.
24.
Schmuziger N, Schimmann F, àWengen D, Patscheke J, Probst R: Long-term assessment after implantation of the Vibrant Soundbridge device. Otol Neurotol 2006;27:183-188.
25.
Schraven SP, Hirt B, Goll E, Heyd A, Gummer AW, Zenner HP, Dalhoff E: Conditions for highly efficient and reproducible round-window stimulation in humans. Audiol Neurotol 2012;17:133-138.
26.
Schraven SP, Hirt B, Gummer AW, Zenner HP, Dalhoff E: Controlled round-window stimulation in human temporal bones yielding reproducible and functionally relevant stapedial responses. Hear Res 2011;282:272-282.
27.
Shimizu Y, Puria S, Goode RL: The floating mass transducer on the round window versus attachment to an ossicular replacement prosthesis. Otol Neurotol 2011;32:98-103.
28.
Sim JH, Chatzimichalis M, Lauxmann M, Röösli C, Eiber A, Huber AM: Complex stapes motions in human ears. J Assoc Res Otolaryngol 2010;11:329-341.
29.
Snik A, Cremers C: Audiometric evaluation of an attempt to optimize the fixation of the transducer of a middle-ear implant to the ossicular chain with bone cement. Clin Otolaryngol Allied Sci 2004;29:5-9.
30.
Snik AF, Mylanus EA, Cremers CW, Dillier N, Fisch U, Gnadeberg D, Lenarz T, Mazolli M, Babighian G, Uziel AS, Cooper HR, O'Connor AF, Fraysse B, Charachon R, Shehata-Dieler WE: Multicenter audiometric results with the Vibrant Soundbridge, a semi-implantable hearing device for sensorineural hearing impairment. Otolaryngol Clin North Am 2001;34:373-388.
31.
Sterkers O, Boucarra D, Labassi S, Bebear JP, Dubreuil C, Frachet B, Fraysse B, Lavieille JP, Magnan J, Martin C, Truy E, Uziel A, Vaneecloo FM: A middle ear implant, the Symphonix Vibrant Soundbridge: retrospective study of the first 125 patients implanted in France. Otol Neurotol 2003;24:427-436.
32.
Stieger C, Bernhard H, Waeckerlin D, Kompis M, Burger J, Haeusler R: Human temporal bones versus mechanical model to evaluate three middle ear transducers. J Rehabil Res Dev 2007;44:407-416.
33.
Streitberger C, Perotti M, Beltrame MA, Giarbini N: Vibrant Soundbridge for hearing restoration after chronic ear surgery. Rev Laryngol Otol Rhinol (Bord) 2009;130:83-88.
34.
Todt I, Seidl RO, Gross M, Ernst A: Comparison of different vibrant soundbridge audioprocessors with conventional hearing aids. Otol Neurotol 2002;23:669-673.
35.
Truy E, Eshraghi AA, Balkany TJ, Telishi FF, Van De Water TR, Lavieille JP: Vibrant soundbridge surgery: evaluation of transcanal surgical approaches. Otol Neurotol 2006;27:887-895.
36.
Verhaegen VJ, Mulder JJ, Cremers CW, Snik AF: Application of active middle ear implants in patients with severe mixed hearing loss. Otol Neurotol 2012;33:297-301.
37.
Zenner HP, Leysieffer H: Active electronic cochlear implants for middle and inner ear hearing loss - a new era in ear surgery. I. Basic principles and recommendations on nomenclature. HNO 1997;45:749-757.
38.
Zenner HP, Rodriguez Jorge J: Totally implantable active middle ear implants: ten years' experience at the University of Tübingen. Adv Otorhinolaryngol 2010;69:7284.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.